Stay informed with the latest litigation news. Explore now

IP Verse

Duke University patent opposition analysis

Latest patents of Duke University opposed by its competitors

Explore Duke University's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 28, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3823992
Dec 13, 2023Anti-Lypd3 Car T-Cell Therapy For The Treatment Of Cancer1
EP3773486
Dec 6, 2023Methods Of Treating Autism Spectrum Disorders Using Human Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells1
EP3122426
Jan 18, 2023Method Of Treating Cancer Using Selective Estrogen Receptor Modulators2
EP3360979
May 20, 2020Tert Promoter Mutations In Gliomas And A Subset Of Tumors1

Top competitors of Duke University

Top competitors of Duke University based on patent oppositions.